A public discussion @ the Cambridge Science Festival
The concept of personalised medicine understandably attracts a lot of attention. Genomics enable us to better stratify patients into specific treatment groups based on their genetic make-up and risk factors. Equally, stem cells offer the ability to test drugs and therapies on copies of a patient's own cells. Lots of progress is being made in this area but how much data is involved, who has access to it and how is it protected?
These were the key issues that our diverse panel of experts attempted to tackle during out 'Stem Cells, Big Data & Personalised Medicine' event. Our speakers were: Dr Maria Alcolea, Dr Paul Bertoni, Dr Nicolas Le Novere, Dr Chris Kirton & Dr Minal Patel.
A key objective of the event was to be responsive to what the audience wanted to hear about so we had lots of opportunities to comment, ask questions and change the direction of the discussion. This made for a very lively and vibrant conversation that covered a very broad range of topics. This event was co-hosted by four leading bio-medical research institutes: Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute; Wellcome Trust Sanger Institute; Wellcome Trust / Cancer Research UK Gurdon Institute; and The Babraham Institute.